Related Experiment Video
Updated: Mar 18, 2026

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
Published on: October 21, 2022
The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression
Lei Yu1, Xuejun Gong2, Lei Sun3
1Department of Infectious Disease,The Fourth Hospital of Harbin Medical University, Harbin 150001, Heilongjiang, China.
Abstract:
CircRNAs are a class of endogenous RNA that regulates gene expression at the post-transcriptional or transcriptionallevel through interacting with other molecules or microRNAs. Increasing studies have demonstrated that circRNAs play a crucial role in biology processes. CircRNAs are proved as potentialbiomarkers in many diseases including cancers. However, the role of Cdr1as in Hepatocellular carcinoma (HCC) remains to be elucidated. We demonstrated that Cdr1as expression was upregulated in HCC tissues compared with the adjacent non-tumor tissues. In addtion, miR-7 expression was downregulated in HCC tissues compared with the adjacent non-tumor tissues. Moreover, the expression level of miR-7 was inversely correlated with that in HCC tissues. Knockdown of Cdr1as suppressed the HCC cell proliferation and invasion. Overexpression of miR-7 inhibited the HCC cell proliferation and invasion. Overexpression of miR-7 could suppress the direct target gene CCNE1 and PIK3CD expression. Knockdown of Cdr1as suppressed the expression of miR-7 and also inhibited the CCNE1 and PIK3CD expression. Furthermore, knockdown of Cdr1as suppressed the HCC cell proliferation and invasion through targeting miR-7. These data suggested that Cdr1as acted as an oncogene partly through targeting miR-7 in HCC.
Insights
Circular RNAs (circRNAs) like Cdr1as are implicated in cancer. This study shows Cdr1as promotes hepatocellular carcinoma (HCC) by downregulating miR-7, offering potential therapeutic targets.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Circular RNAs (circRNAs) regulate gene expression and are implicated in various diseases.
- Hepatocellular carcinoma (HCC) is a major global health concern with complex molecular underpinnings.
- The specific role of Cdr1as in HCC pathogenesis requires further investigation.
Purpose of the Study:
- To elucidate the role of Cdr1as in hepatocellular carcinoma (HCC).
- To investigate the relationship between Cdr1as, miR-7, and HCC progression.
- To explore Cdr1as as a potential biomarker and therapeutic target in HCC.
Main Methods:
- Quantitative real-time PCR to assess Cdr1as and miR-7 expression levels in HCC tissues and adjacent non-tumor tissues.
- Cell proliferation and invasion assays to evaluate the functional impact of Cdr1as and miR-7.
- Western blotting to detect the expression of target genes CCNE1 and PIK3CD.
Main Results:
- Cdr1as expression was significantly upregulated in HCC tissues compared to non-tumor tissues.
- miR-7 expression was downregulated in HCC tissues and inversely correlated with Cdr1as levels.
- Knockdown of Cdr1as or overexpression of miR-7 suppressed HCC cell proliferation and invasion, partly via CCNE1 and PIK3CD.
- Cdr1as knockdown inhibited HCC progression by targeting miR-7.
Conclusions:
- Cdr1as functions as an oncogene in HCC.
- Cdr1as promotes HCC cell proliferation and invasion by sponging miR-7.
- Cdr1as represents a potential diagnostic biomarker and therapeutic target for HCC.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
MicroRNAs
MicroRNAs
Experimental RNAi
Abnormal Proliferation

